Term
|
Definition
Non-selective Beta adrenergic receptor. Increases HR (B1) with a decrease in TPR (B2). Because there is little A1 response, there is no reflex vagal discharge.
Bronchial and GI smooth muscle relaxation also occur
Use primarily as a cardiac stimulant
Side effects are similar to epinephrine, but less acute, metabolized by COMT |
|
|
Term
|
Definition
B1 selective agonist with modest a1 activity. There is increased CO with no associated change in peripheral resistance
Used in short term treatment of cardiac decompensation, increased CO and SV in pts with acute MI
AE: Inc HR and BP, arrhythmias, inc myocardial O2 demand, development of tolerance |
|
|
Term
|
Definition
Selective B2 receptor agonist, primarily used in tx of obstructive airway disease and acute bronchospasm. Can also be used parenterally for status asthmaticus (worsening of asthma). Also decreases release of leukotrienes and histamine
More resistant to MAO and COMT than other drugs, so it has longer duration of action. |
|
|
Term
|
Definition
Selective B2 receptor agonist, primarily used in tx of obstructive airway disease and acute bronchospasm. Also decreases release of leukotrienes and histamine. Commonly seen in asthmatic inhalers
More resistant to MAO and COMT than other drugs, so it has longer duration of action. |
|
|
Term
|
Definition
Selective a1 agonist that causes vasoconstriction and greatly inc PVR, with reflex dec in HR. Therefore, it is useful in patients in shock and with hypotension, also in maintenance of BP during surgical procedures.
Largely replaced by adenosine, verapamil or cardioversion now |
|
|
Term
|
Definition
Selective a1 agonist that causes vasoconstriction and greatly inc PVR, with reflex dec in HR. Commonly used to dilate pupils (mydriatic) and also as a nasal decongestant (stops secretions)
Largely replaced by adenosine, verapamil or cardioversion now
Can be used to diagnose Horner's Syndrome with direct local application since patients will have supersensitive receptors
|
|
|
Term
|
Definition
Selective a2 agonist that acts on receptors in the CNS to decrease symp outflow. This produces a decrease in BP and HR.
Oral administration for anti-HTN, while IV administration produces a transient inc in BP followed by a prolonged decreased BP.
Used in HTN, migraine, and Tourette's/ADHD with methylphenidate
AE: Dry mouth and sedation!! Also, commonly associated with withdrawal syndrome if discontinued abruptly.
|
|
|
Term
|
Definition
Selective a2 agonist that decreases intraocular pressure via decreasing production of aqueous humor.
Effective in glaucoma |
|
|
Term
|
Definition
Metabolized to alpha-methylnorepinephrine which activates central a2 receptros to dec sympathetic outlfow and decrease BP
Used in HTN |
|
|
Term
|
Definition
Indirect acting sympathomimetic that increases release of NE from nerve terminals and decreases Uptake 1. This has similar effects to a CA agonist, increasing BP, triggering reflex vagal discharge, and also enhances concentration, and produces euphoric effects
Can lead to restlessness, talkativeness, psychological dependence, and "psychosis." Can be used for obesity, narcolepsy and appetite suppression, but it's non-selective blocking of dopamine reuptake makes it extremely addictive |
|
|
Term
|
Definition
Crystal meth - Indirect acting sympathomimetic that increases release of NE from nerve terminals and decreases Uptake 1. This has similar effects to a CA agonist, increasing BP, triggering reflex vagal discharge, and also enhances concentration, and produces euphoric effects. Its CNS effects tend to be greater than its peripheral effects, making it extremely addictive
Can lead to restlessness, talkativeness, psychological dependence, and "psychosis." Can be used for obesity, narcolepsy and appetite suppression, but it's non-selective blocking of dopamine reuptake makes it extremely addictive |
|
|
Term
|
Definition
Ritalin - Indirect acting sympathomimetic that increases release of NE from nerve terminals and decreases Uptake 1. Has similar effects as CA agonist: increases BP, triggers reflex vagal discharge, and also enhances concentration, and produces euphoric effects. Effective for ADHD because it has pronounced mental effects
Can lead to restlessness, talkativeness, psychological dependence, and "psychosis." Can be used for obesity, narcolepsy and appetite suppression, but it's non-selective blocking of dopamine reuptake makes it extremely addictive |
|
|
Term
|
Definition
Indirect acting sympathomimetic that increases release of NE from nerve terminals and decreases Uptake 1. Has similar effects to a CA agonist: increases BP, triggers reflex vagal discharge, and enhances concentration, produces euphoric effects. Effective in ADHD
Can lead to restlessness, talkativeness, anorexia. Unlike other indirect sympathomimetic, this one is specific to inhibiting NE reuptake, and does not inhibit dopamine --> No dependence/reward circuitry, very little abuse of drug
|
|
|
Term
|
Definition
Ecstasy - Indirect acting sympathomimetic that increases release of NE from nerve terminals and decreases Uptake 1. This has similar effects to a CA agonist, increasing BP, triggering reflex vagal discharge, and also enhances concentration, and produces euphoric effects
Can lead to restlessness, talkativeness, psychological dependence, and "psychosis." Can be used for obesity, narcolepsy and appetite suppression, but it's non-selective blocking of dopamine reuptake makes it extremely addictive |
|
|
Term
|
Definition
Similar to other indirect sympathomimetics but only decreases Uptake 1 (no inc in EPI release). This has similar effects to a CA agonist, increasing BP, triggering reflex vagal discharge, and also enhances concentration, and produces euphoric effects
Can lead to restlessness, talkativeness, psychological dependence, and "psychosis." Can be used for obesity, narcolepsy and appetite suppression, but it's non-selective blocking of dopamine reuptake makes it extremely addictive |
|
|
Term
|
Definition
Both a direct and indirect sympathomimetic, acting on alpha and beta receptors, and also inc NE release. Similar to NE and EPI with longer duration. Inc HR, CO, PVR, produces bronchodilation and CNS stimulation. Useful for bronchodilation and hypotension
Associated with tachyphylaxis, many AE incl terrible palpitations, HTN, arrhythmias, tremors, stroke. Very limited use because of this. |
|
|
Term
|
Definition
Indirect sympathomimetic that causes release of NE from nerve terminal and acts as a competitor for NE reuptake.
Found in many foods incl cheese, pickled foods, red wine and is rapidly degraded by MAO. See problems when patients are taking MAO inhibitors with patients developing hypertensive crises and death
Not used therapeutically |
|
|
Term
|
Definition
Irreversible non-selective alpha adrenergic blocker that dec PVR, dec BP (only in upright position), increases NE release (via a2 blockade), and increases HR and CO (because b1 receptors are maintained)
AE include postural hypotension, reflex tachycardia and arrhythmias
Effective in pheochromocytoma (CA producing tumor of adrenal medulla) |
|
|
Term
|
Definition
Reversible, non-selective alpha adrenergic blocker that dec PVR, dec BP in upright position, increases NE release (via a2 blockade), and increases HR and CO (because b1 receptors are maintained). Also stimulates GI smooth muscle and increases gastric acid secretion
AE include hypotension, reflex tachycardia and arrhythmias
Effective in short term HTN control in pheochromocytoma, and treatment of hypertensive crises. More potent than tolazoline
|
|
|
Term
|
Definition
Reversible, non-selective alpha adrenergic blocker that dec PVR, dec BP in upright position, increases NE release (via a2 blockade), and increases HR and CO (because b1 receptors are maintained). Also stimulates GI smooth muscle and increases gastric acid secretion
AE include hypotension, reflex tachycardia and arrhythmias
Effective in short term HTN control in pheochromocytoma, and treatment of hypertensive crises. Also used in persistent pulmonary HTN of the newborn. Less potent than phentolamine |
|
|
Term
|
Definition
Selective a1 receptor blocker that decreases PVR, VR with no significant change in HR or CO (no effect on b1).
Most patients experience first dose phenomenon, with postural hypotension and syncope. Start at night.
Used in tx of HTN, refractory CHF (to dilate BV) and benign prostatic hyperplasia (to reduce resistance to flow) |
|
|
Term
|
Definition
Selective a2 receptor blocker that increases symp outflow centrally and inc release of NE peripherally (by decreasing negative feedback).
Used for treatment of male sexual dysfunction, though largely replaced by NO now |
|
|
Term
|
Definition
Many actions including blockade of alpha receptors. Also blocks serotonin (5HT) receptors and DA receptors with many effects in the CNS
USed for migraines and stimulation of postpartum contraction of the uterus |
|
|
Term
CV Effects of Beta Blockers |
|
Definition
Little effects on heart at rest, with profound effects on heart in stress, or heart of hypertensive. Decreases HR, FOC, AV CV, and inhibit the vasodilating response to b-adrenergic stimulation
Marked attenuation of exercise-induced increases in HR and FOC, which can prevent angina with exertion. BP is also decreased because of decreased heart activity, though PVR does initially rise
AE: Long term administration in hypertensives leads to persistent fall in CO |
|
|
Term
Respiratory and Metabolic
Effects of Beta Blockers |
|
Definition
Bronchodilation mediated primarily via b2 so use of beta blockers in asthmatics can produce life-threatening bronchoconstriction. This can be avoided by using a b1 selective blocker. Can also treat bronchoconstriction to be able to continue use of beta blocker
Catecholamines mobilize glucose in response to hypoglycemia and side effects of this (inc HR etc) are commonly used by diabetics to sense hypoglycemia. Use of beta blockers blunts these peripheral signs, so b2 blockers are preferred in diabetics
|
|
|
Term
Side Effects of Beta Blockers |
|
Definition
Life-threatening Bradycardia in pts with AV node conduction defects, exacerbation of Angina if there is abrupt withdrawal (receptor Supersensitivity), increased Airway resistance, Fatigue, Nightmares, Blunting of signs of hypoglycemia |
|
|
Term
Indications for Beta Blockers |
|
Definition
HAM CHAGAM
Hypertension, Angina, Myocardial Infarction
CHF, Hyperthyroidism, ventricular and supraventricular Arrhythmias, Glaucoma, Acute panic attacks (decreases symptoms, emotion itself), Migraine prophylaxis |
|
|
Term
|
Definition
Prototypic non-selective beta blocker, highly lipophilic and well absorbed with PO. No ISA. Undergoes extensive first-pass metabolism so high doses required, and highly protein bound, so drug interactions common
Commonly used in CHF, migraines and stage fright |
|
|
Term
Nadolol and
Timolol
(2 mechanisms) |
|
Definition
N - Non-selective beta blocker with no ISA and long duration of action, allowing dosing only 1/day
T - Short acting, non-selective beta blocker with no ISA used for glaucoma and functions by decreasing production of aqueous humor |
|
|
Term
|
Definition
Prototypic drug with intrinsic sympathomimetic activity (ISA aka partial agonist). Though it is a beta blocker, at rest there is mild stimulatory activity of the beta system, while there is full beta blocker activity with stress.
Non-selective beta blocker |
|
|
Term
|
Definition
Non-selective beta blocker that also blocks a1 receptors, and can inhibit reuptake of NE. There is a decreased peripheral BP with no reflex tachycardia because of the beta blocking activity
no ISA |
|
|
Term
|
Definition
Non-selective beta blocker that acts as an anti-arryhythmic agent |
|
|
Term
|
Definition
Non-selective beta block that also blocks a1 receptors. b1 blocking has longer duration. No ISA |
|
|
Term
|
Definition
B1 selective beta blocker, that is hydrophilic and therefore has limited CNS activity. No ISA |
|
|
Term
|
Definition
B1 selective beta blocker used for HTN and stable angina, but contraindicated in patients with acute MI associated with bradycardia, heart block or heart failure.
No ISA |
|
|
Term
|
Definition
Short duration, b1 selective, beta blocker with actions similar to metoprolol (used in HTN and stable angina).
No ISA. Must be given IV |
|
|
Term
|
Definition
Similar to metoprolol, but has Intrinsic sympthomimetic activitiby (ISA aka partial agonist). This means at rest, there is mild beta adrenergic stimulation by the drug, but there is full beta blocking with stress. |
|
|
Term
|
Definition
Primarily acts on muscarinic receptors on parasympathetic target organs with direct effects on CV system including slowing heart rate and conduction velocity. Also, if given exogenously, they can cause peripheral vasodilation
Side effects include all undesired outcomes (urination, gut motility, lacrimation, salivation, bronchoconstriction, pupil dilation)
Can also stimulate autonomic ganglia
|
|
|
Term
|
Definition
Choline ester that acts on both nicotinic and muscarinic receptors. This makes it relatively counterproductive to use because of activation at autonomic ganglia. Resistant to hydrolysis by AChE
Some preference for urinary and GI tract make it rel effective, but use primarily limited to local application to eye, which contracts the ciliary muscle and opens the trabecular meshwork to allow aqueous humor outflow in tx of glaucoma
AE include DUMBELS, don't use in asthmatics, those with hyperthyroidism, coronary insufficiency or peptic ulcer |
|
|
Term
|
Definition
Choline ester that acts on muscarinic receptors with little nicotinic activity. This makes it more useful than carbachol. Resistant to hydrolysis by AChE
Some preference for urinary and GI tract make it effective for treatment of urinary retention or constipation.
AE include DUMBELS, don't use in asthmatics, those with hyperthyroidism, coronary insufficiency or peptic ulcer
|
|
|
Term
|
Definition
Alkaloid that acts primarily on ACh muscarinic receptors and is especially stimulatory on sweat glands.
Can also be used to treat glaucoma via local application which contracts the ciliary muscle, opens the trabecular meshwork and allows outflow of aqueous humor. Better tolerated than anti-AChEs |
|
|
Term
|
Definition
Endogenous alkaloid that is also found in poisonous mushrooms. Acts almost exclusively at ACh muscarinic receptors and can produce salivation, lacrimation, nausea, bradycardia, hypotension, shock, diarrhea, headache.
Treat intoxication with anti-muscarinic atropine |
|
|
Term
|
Definition
Anticholinesterase alcohol that is polarized, so it has preferred action at the NMJ. Functions by reversibly binding to the active site of AChE leading to decreased degradation of ACh
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are undesired cholinergic effects
Can be used to determine AChE dosing efficacy in Myasthenia Gravis. If the muscle weakness is due to MG, giving will increase muscle strength. If the muscle weakness is due to depolarization block, giving will actually worsen the muscle tone
|
|
|
Term
|
Definition
Anticholinesterase alcohol that is non-polar. Functions by reversibly binding to active site of AChE leading to decreased degradation of ACh
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are any undesired cholinergic effects
Use is primarily treatment of mild to moderate alzheimers, but does not slow disease progression
|
|
|
Term
|
Definition
Anticholinesterase carbamate ester that is polarized, so it has preferred action at the NMJ. Functions by forming a covalent bond with the active site of AChE leading to decreased degradation of ACh. Longer duration than alcohols
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are any undesired cholinergic effects
Used in Myasthenia gravis, termination of effects of neuromuscular blockers, postoperative ileus (initiates GI motility)
|
|
|
Term
|
Definition
Anticholinesterase carbamate ester. Functions by forming a covalent bond with the active site of AChE leading to decreased degradation of ACh. Longer duration than alcohols
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are any undesired cholinergic effects
Used in glaucoma
|
|
|
Term
|
Definition
Anticholinesterase carbamate ester. Functions by forming a covalent bond with the active site of AChE leading to decreased degradation of ACh. Longer duration than alcohols
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are any undesired cholinergic effects
Used in myasthenia gravis (longer duration than neostigmine)
|
|
|
Term
|
Definition
Anticholinesterase that functions by reversibly binding to active site AChE and inactivating it leading to decreased degradation of ACh. Longer duration than alcohols
Affects all parasymp target organs as well as muscles and has predictable effects there. In muscles, however, low doses can promote contraction, while higher doses lead to paralysis due to a loss of ion gradient (depolarization block). AE are any undesired cholinergic effects
Used in Myasthenia gravis (long duration)
|
|
|
Term
|
Definition
Organophosphate Anti-ChE that phosphorylates the active site of AChE to irreversibly inhibit it. The phosphorylated enzyme can then undergo an aging process which strengthens the bond.
Has predictable effects on parasymp target organs and the NMJ and can lead to depolarization block. Side effects are DUMBEL.
Used in long duration treatment of glaucoma |
|
|
Term
|
Definition
Organophosphate anti-ChE that is primarily used as a pesticide. Functions by irreversibly phosphorylating the active site of AChE. Enzyme can undergo an aging process that further strengthens the bond.
AE include DUMBELS, lots of intoxication in humans because of irreversible binding |
|
|
Term
|
Definition
Organophosphate anti-AChE that function by irreversibly phosphorylating the active site of AChE. This can further undergo an aging process which strengthens the bond.
These three agents are used as nerve gases and cause rapid respiratory distress and NM paralysis. Poisoning has to be treated early with 2-PAM and atropine to reverse the effects |
|
|
Term
|
Definition
Reactivate AChE after inactivation by organophosphates. Exerts a strong nucleophilic atack to break the phosphorus-enzyme bond. Effective as an antidote for nerve poisoning. Effective at NMJ but do not enter the CNS, so they must be supplemented with atropine for full effects
Ineffective if the "aging process" has already occurred |
|
|
Term
|
Definition
Competetive ACh antagonist, specific to muscarinic receptors. It has limited CNS penetration and is typically the anti-cholinergic of choice
Can be used for GI tract disorders (duodenal ulcer, increased tone/motility etc), pupillary dilation (accompanied with relaxation of ciliary muscle), decreasing secretions, increasing heart rate, and in urinary incontinence.
AE include all above, that are not desired. Do not use in patients with glaucoma, prostatic hypertrophy (further retention), or those with GERD (slows GI emptying) |
|
|
Term
|
Definition
Muscarinic antagonist that has good CNS penetration and is therefore useful in treatment of motion sickness. It also has central depressive effects, so it can cause fatigue and tiredness.
AE include all effects of inhibiting parasympathetic outflow, plus the CNS depression |
|
|
Term
|
Definition
Muscarinic antagonist that is primarily used to treat ophthamologic concerns. It acts as a mydriatic and allows flattening of the lens for distant vision. Relatively short duration
AE include all effects of inhibiting parasympathetic outflow, plus the CNS depression. Avoid use in pts with glaucoma, prostatic hypertrophy, or GERD |
|
|
Term
|
Definition
Muscarinic antagonist that has slight selectivity for M1 receptors, so its effects are more exaggerated in the GI tract. It is therefore useful for peptic ulcer, though other agents have largely replaced it. No CNS effects
AE include all effects of inhibiting parasympathetic outflow, without any CNS depression. Avoid in patients with glaucoma, prostatic hypertrophy, or GERD |
|
|
Term
|
Definition
Muscarinic antagonist that is relatively non-specific, but has slightly higher affinity for M2 and M3 (targets the bladder). It is therefore useful in urinary incontinence.
AE are relatively few because it does have some selectivity, though normal ACh inhibition can be seen. Urinary retention can result |
|
|
Term
|
Definition
Muscarinic antagonist used as an inhalational for treatment of asthma and other obstructive pulmonary diseases. Produces bronchodilation, and is poorly absorbed
AE very few because it is poorly absorbed and effects therefore limited to mouth and airways |
|
|
Term
|
Definition
Non-polarizing (competetive), neuromuscular blocker. Competetively blocks ACh action at NMJ but doesn't interfere with contractile capabilities of muscle. Characteristics of paralysis are small, rapidly moving muscles with limbs, neck, trunk first then intercostals, then diaphragm. Interaction with anti-cholinesterases reverse or decrease the block because of the increased ACh levels at the NMJ
Can be used as an adjunct to anesthesia, facilitate intubation
AE include hyperkalemia, CV collapse, induction of histamine release (with associated effects) |
|
|
Term
|
Definition
Depolarizing neuromuscular blocker; acts in 2 phases. In phase 1, drug acts as nicotinic agonist and eventually induces a depolarization block (with flaccid paralysis). In phase 2, with continued exposure, the membrane repolarizes, but remains insensitive to ACh and is similar to non-depolarizing. However, anti-cholinesterases will not decrease the block, because of receptor desensitization
Can be used as an adjunct to anesthesia, facilitate intubation
AE include hyperkalemia, CV collapse, malignant hyperthermia (autosomal dominant disease with severe muscle contractions and heat generation on application of anesthesia)
|
|
|
Term
|
Definition
Ganglionic stimulant, followed by depressant that exerts complex effects on the body, often activating several opposing actions on different organ systems. Also stimulates CA release from adrenal medulla, though higher doses inhibit release. Initial stimulation of NMJ, followed by paralysis. Can be a CNS stimulant, producing tremors, and generally increases HR and BP. |
|
|
Term
|
Definition
Ganglionic blocking agent that inhibits autonomic outflow, so its effects depend on the predominant system affecting each organ. It causes the opposite effects of the predominant tone.
All organ systems have predominant parasympathetic tone except vasculature, apocrine sweat glands, and the ventricles. An example of effects are vasculature vasodilates because predominant tone is sympathetic and vasoconstriction is inhibited.
Used in hypertensive crisis (largely replaced) and autonomic hyperreflexia |
|
|
Term
|
Definition
Ganglionic blocking agent that inhibits autonomic outflow, so its effects depend on the predominant system affecting each organ. It causes the opposite effects of the predominant tone.
All organ systems have predominant parasympathetic tone except vasculature, apocrine sweat glands, and the ventricles. An example of effects are vasculature vasodilates because predominant tone is sympathetic and vasoconstriction is inhibited.
Used in hypertensive crisis (largely replaced) and autonomic hyperreflexia |
|
|
Term
|
Definition
Blocks transport of dopamine into presynaptic vesicles in adrenergic neurons and the adrenal medulla, effectively inhibiting NE and EPI synthesis.
Effective in hypertension, but not used very much anymore |
|
|
Term
|
Definition
Inhibits action potential that allows release of NE and therefore acts by inhibiting release.
Useful in hypertension. |
|
|
Term
|
Definition
Inhibits tyrosine hydroxylase from converting Tyr into L-Dopa. Effective at inhibiting CA synthesis |
|
|
Term
Tricyclic Anti-Depressants |
|
Definition
Similar to other indirect sympathomimetics but only decreases Uptake 1 (no inc in EPI release). This has similar effects to a CA agonist, increasing BP, triggering reflex vagal discharge, and also enhances concentration, and produces euphoric effects |
|
|